Drug-induced hyperthermia

Lore & Background

Drug-induced hyperthermia arises when a drug intended to treat a patient instead triggers a hypermetabolic state, leading to fever. The mechanisms include interference with heat dissipation, increased metabolic rate, immune responses, mimicking of endogenous pyrogen, or tissue damage. Triggers range from direct drug effects (e.g., lamotrigine, progesterone, chemotherapeutics causing tumor necrosis) to side effects of stimulants and entactogens like cocaine, MDMA, and methamphetamine.

Reader's Guide

Drug-induced hyperthermia is significant as a potentially life-threatening adverse drug reaction. Its recognition is critical in clinical settings, as it can result from common medications such as antibiotics, sulfa drugs, or antipsychotics (e.g., haloperidol, chlorpromazine) via neuroleptic malignant syndrome. Treatment centers on discontinuing the offending agent, with supportive cooling measures like ice packs and, for severe cases (fever at or above ~104°F or 40°C), aggressive cooling and benzodiazepines. The condition underscores the need for careful drug monitoring and prompt intervention to prevent morbidity.

Did You Know?

• Drug-induced fever can be caused by drugs such as lamotrigine, progesterone, or chemotherapeutics causing tumor necrosis.
• Stimulants and entactogens like cocaine, MDMA, and methamphetamine can trigger drug-induced hyperthermia.
• Neuroleptic malignant syndrome is a rare, life-threatening hyperpyrexia caused by antidopaminergic drugs, mostly antipsychotics.
• Serotonin syndrome results from excessive serotonergic activity, usually due to combined use of serotonergic drugs.

Pathophysiology & Mechanisms

Drug-induced fever represents a paradoxical adverse reaction in which medications prescribed to treat a condition instead push the body into a hypermetabolic state that elevates temperature. The underlying mechanisms are remarkably varied. A drug may disrupt the body's ability to shed heat through peripheral pathways, effectively trapping warmth inside. Alternatively, it can accelerate the metabolic rate, generating excess internal heat. Some agents trigger a cellular or humoral immune response, flooding the system with inflammatory mediators. Others act as mimics of the body's own pyrogens—substances that naturally signal the hypothalamus to raise the thermal set point. Still others cause direct tissue damage that provokes a febrile response. This diversity of pathways explains why so many unrelated drug classes can produce the same clinical picture of elevated temperature, making identification of the offending agent a critical diagnostic challenge for clinicians.

Causative Agents & Triggers

The spectrum of drugs capable of provoking hyperthermia is remarkably broad. Direct causation is seen with lamotrigine, progesterone, and chemotherapeutic agents that induce tumor necrosis. Stimulants and entactogens—including cocaine, MDMA, methamphetamine, PMA, and 4-MTA—can produce fever as a possible side effect. Conventional medications such as antibiotics and sulfa drugs may trigger fever as an adverse reaction. Withdrawal from opioids like heroin or fentanyl has also been documented as a precipitant. Among the most dangerous presentations are neuroleptic malignant syndrome, a rare but life-threatening hyperpyrexia linked to antidopaminergic drugs such as haloperidol and chlorpromazine, and serotonin syndrome, which arises from excessive serotonergic activity typically caused by combining serotonergic agents like antidepressants, stimulants, and triptans. 5HT2A agonists such as psilocybin and LSD, as well as malignant hyperthermia, round out the list of recognized triggers.

Clinical Management & Treatment

The cornerstone of managing drug-induced fever is identifying and removing the offending agent, whether that means discontinuing a prescribed medication or addressing illicit substance use. Once the trigger is eliminated, supportive measures become the primary intervention. Simple cooling strategies such as ice packs applied to the body help bring temperature back within the physiologic range. When the fever escalates to severe levels—generally at or above approximately 104°F (40°C)—more aggressive cooling becomes necessary. An ice bath may be administered to rapidly reduce core temperature. In these critical situations, pharmacologic adjuncts such as benzodiazepines can be employed to manage associated agitation, muscle rigidity, or sympathetic overdrive. The treatment approach is thus tiered: from supportive comfort measures for moderate presentations to intensive cooling and medication for life-threatening hyperpyrexia, always anchored by the fundamental step of stopping the causative drug.

Severe Syndromes & Life-Threatening Presentations

While many instances of drug-induced fever resolve with supportive care, certain syndromes represent medical emergencies with potentially fatal outcomes. Neuroleptic malignant syndrome stands out as a rare but devastating hyperpyrexia triggered by antidopaminergic drugs, most commonly antipsychotics like haloperidol and chlorpromazine. The condition is classified as life-threatening and demands urgent intervention. Serotonin syndrome presents another critical scenario, arising when excessive serotonergic activity accumulates—frequently through the combined use of multiple serotonergic drugs such as antidepressants, stimulants, and triptans. The resulting hyperthermia can be profound. Malignant hyperthermia, though distinct in its pharmacogenetic basis, is also listed among recognized drug-induced hyperthermic events. These severe presentations underscore why drug-induced fever cannot be dismissed as a minor side effect; in its most extreme forms, it constitutes a hypermetabolic crisis requiring immediate, aggressive clinical management to prevent organ failure and death.